Multiple Sclerosis News Today

Explore the details: bit.ly/4inotOe As November begins, columnist Desiree Lama thinks about what finding gratitude looks like when you are living with multiple sclerosis. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Chronic illness: Where sleeping is a skill and waking up is the challenge. #TiredAllTheTime

Explore the details: bit.ly/4eaJk50 A Phase 2 trial found that a lower dose of nasal foralumab significantly reduced brain inflammation markers in people with nonactive SPMS. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Discover more: bit.ly/4iyBgfw Experimental MS therapy remibrutinib reduced relapse rates and brain lesion activity more than Aubagio in two Phase 3 trials. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

“Only you can prevent flare-ups.” Me: cries in autoimmune #SpoonieLife

Explore the details: multiplesclerosisnewstoday.c… A study from Sweden links MS therapy rituximab to a higher risk of inflammatory bowel disease than three other treatments. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Being chronically ill means my health is always trending ... backward. #ChronicLife

I stopped waiting to be “better" and forced myself to start living as I am. #ChronicIllnessWarrior

Every day is a conversation between my limits and my will. #ChronicallyIll

Take a closer look: multiplesclerosisnewstoday.c… Greater physical disability is associated with cognitive problems in people with multiple sclerosis, according to a review study. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Pain is my shadow — it doesn’t define me, but it follows me everywhere. #ChronicPain

Get the scoop: multiplesclerosisnewstoday.c… MS therapies showed differences in relapse rates among newly diagnosed patients, but no significant disability differences over two years. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Get the scoop: multiplesclerosisnewstoday.c… Physical activity programs for people with MS appear feasible and well received, but more research is needed on their use in clinical care. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

I celebrate the soft kind of endurance — the quiet “I made it.” #InvisibleIllness

Explore the details: multiplesclerosisnewstoday.c… Trial data suggest a single infusion of the experimental CAR T-cell therapy zola-cel may stabilize disability in relapsing or progressive MS. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

My personality is 25% spoonie humor, 75% managing symptoms. #SpoonieChronicles

Discover more: multiplesclerosisnewstoday.c… 'Vaccine fatigue' rose in MS after the COVID-19 pandemic; many patients lacked the protection they thought they had, a German study finds. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

Take a closer look: multiplesclerosisnewstoday.c… Most patients with progressive MS had stable or improved disability scores after experimental CAR T-cell therapy in a small Phase 1 trial. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews

I’m not mad at my body. I’m just still learning to negotiate with it. #ChronicLife

Get the scoop: bit.ly/4i80OBf Early treatment with vidofludimus calcium may lead to less long-term disability in people with progressive forms of MS, data show. #MultipleSclerosis #MS #MultipleSclerosisNewsToday #Bionews